A detailed history of Kendall Capital Management transactions in Mckesson Corp stock. As of the latest transaction made, Kendall Capital Management holds 2,720 shares of MCK stock, worth $1.69 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
2,720
Previous 2,510 8.37%
Holding current value
$1.69 Million
Previous $1.47 Million 8.26%
% of portfolio
0.43%
Previous 0.5%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$479.06 - $630.38 $100,602 - $132,379
210 Added 8.37%
2,720 $1.34 Million
Q2 2024

Aug 12, 2024

BUY
$518.81 - $607.81 $158,237 - $185,382
305 Added 13.83%
2,510 $1.47 Million
Q1 2024

May 10, 2024

BUY
$473.42 - $539.26 $57,757 - $65,789
122 Added 5.86%
2,205 $1.18 Million
Q4 2023

Jan 26, 2024

BUY
$437.42 - $470.64 $24,058 - $25,885
55 Added 2.71%
2,083 $964,000
Q3 2023

Oct 31, 2023

BUY
$402.4 - $446.42 $137,218 - $152,229
341 Added 20.21%
2,028 $882,000
Q2 2023

Jul 28, 2023

BUY
$354.01 - $427.31 $253,825 - $306,381
717 Added 73.92%
1,687 $721,000
Q4 2021

Jan 28, 2022

BUY
$198.21 - $248.9 $192,263 - $241,433
970 New
970 $241,000
Q1 2019

May 08, 2019

SELL
$111.86 - $136.3 $204,144 - $248,747
-1,825 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$108.23 - $136.84 $63,314 - $80,051
-585 Reduced 24.27%
1,825 $202,000
Q3 2018

Oct 29, 2018

SELL
$123.14 - $138.52 $20,318 - $22,855
-165 Reduced 6.41%
2,410 $320,000
Q2 2018

Jul 27, 2018

SELL
$133.4 - $158.13 $113,390 - $134,410
-850 Reduced 24.82%
2,575 $344,000
Q1 2018

May 14, 2018

BUY
$138.75 - $176.72 $13,875 - $17,672
100 Added 3.01%
3,425 $482,000
Q4 2017

Feb 14, 2018

BUY
$135.02 - $162.6 $448,941 - $540,645
3,325
3,325 $519,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $89.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Kendall Capital Management Portfolio

Follow Kendall Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kendall Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Kendall Capital Management with notifications on news.